Geraniol Ameliorates the Motor Behavior and Neurotrophic Factors Inadequacy in MPTP-Induced Mice Model of Parkinson’s Disease

Geraniol modulates tongue and hepatic phase I and phase II conjugation activities and may contribute directly to the chemopreventive activity against experimental oral carcinogenesis

(2013) Arumugam Madankumar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice

(2011) Shih-jei Tsai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

(2011) Timothy J. Collier et al.   NATURE REVIEWS NEUROSCIENCE

Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation

(2011) Young C. Chung et al.   NEUROPHARMACOLOGY

Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinsonʼs disease

(2010) Mohammad Moshahid Khan et al.   BEHAVIOURAL PHARMACOLOGY

The dopamine transporter is differentially regulated after dopaminergic lesion

(2010) Domingo Afonso-Oramas et al.   NEUROBIOLOGY OF DISEASE

Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum

(2010) G. Xu et al.   NEUROSCIENCE

Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model

(2009) Xin Yang et al.   JOURNAL OF GENE MEDICINE

Strain-specific sensitivity to MPTP of C57BL/6 and BALB/c mice is age dependent

(2009) Nikolay M. Filipov et al.   NEUROREPORT

Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation

(2009) Minho Moon et al.   NEUROTOXICITY RESEARCH

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

(2009) Pei-Chun Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

GDNF therapy for Parkinson’s disease

(2008) Murray Hong et al.   Expert Review of Neurotherapeutics

The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains

(2008) Y YASUDA et al.   JOURNAL OF NEUROIMMUNOLOGY

Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism

(2008) Riccardo Viaro et al.   NEUROBIOLOGY OF DISEASE

Treatment of Parkinson’s disease with trophic factors

(2008) Amie L. Peterson et al.   Neurotherapeutics

Plant derived antioxidants – Geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress

(2008) M. Tiwari et al.   TOXICOLOGY IN VITRO

Altered vesicular dopamine storage in Parkinson's disease: a premature demise

(2008) W. Michael Caudle et al.   TRENDS IN NEUROSCIENCES